Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023

6 June 2023

Sofia, Bulgaria, June 5, 2023 - Pursuant to the requirements of Article 100t of the Securities Act, Sopharma AD announces that at its meeting the Board of Directors of the Company resolved to increase the capital on the condition that the shares from the increase are subscribed by the warrant holders, based on a resolution legally adopted at the General Meeting of Warrantholders (GMW) on June 2, 2023. This notification is not a notification pursuant to art. 89t of the Law on Public Offering of Securities.

The expected timetable for implementing the increase is as follows:

Date of disclosure of the announcement under Article 89t(2) of the Securities Act on the website www.x3news.com, on the websites of Sopharma AD and the authorised investment intermediary Sofia International Securities AD	24 August 2023
Commencement date for the exercise of the warrants	1 September 2023
Closing date for payment and subscription of shares	26 September 2023
Registration of the issue of new shares and capital increase in the Commercial Register *	2 October 2023
Registration of the new shares in investors' accounts with the Central Depository *	10 October 2023
Registering the capital increase in the FSC register under art. 30 from the Law on the Financial Supervision Commission *	17 or 19 October 2023
Commencement of trading in the new shares on the BSE *	30 October 2023

* in accordance with the deadlines of the relevant institution

Attachments: Minutes of the meeting of the Board of Directors